|
animals |
15 |
|
lycium barbarum |
11 |
|
neuroinflammation |
11 |
|
humans |
10 |
|
mice |
10 |
|
neuroprotection |
10 |
|
alzheimer's disease |
9 |
|
inflammation |
9 |
|
lycium barbarum polysaccharides |
9 |
|
medical sciences |
9 |
|
aging |
8 |
|
disease models, animal |
8 |
|
lycium - chemistry |
8 |
|
male |
8 |
|
neuroprotective agents - pharmacology |
8 |
|
oxidative stress |
8 |
|
oxidative stress - drug effects |
8 |
|
alzheimer’s disease |
7 |
|
apoptosis |
7 |
|
cells, cultured |
7 |
|
glaucoma |
7 |
|
lc3 |
7 |
|
microglia |
7 |
|
rats |
7 |
|
rats, sprague-dawley |
7 |
|
stress |
7 |
|
autolysosome |
6 |
|
autophagosome |
6 |
|
cerebral ischemia |
6 |
|
cytoskeleton |
6 |
|
drugs, chinese herbal - pharmacology |
6 |
|
female |
6 |
|
flux |
6 |
|
fructus lycii |
6 |
|
lysosome |
6 |
|
phagophore |
6 |
|
phosphorylation |
6 |
|
psychiatry and neurology gerontology and geriatrics |
6 |
|
retina |
6 |
|
tau |
6 |
|
vacuole |
6 |
|
alanine transaminase - blood |
5 |
|
alzheimer disease |
5 |
|
animal experiment |
5 |
|
anti-aging |
5 |
|
anti-inflammatory agents - isolation & purification - pharmacology |
5 |
|
antioxidants - isolation & purification - pharmacology |
5 |
|
axon beading |
5 |
|
beta-amyloid |
5 |
|
carbon tetrachloride |
5 |
|
cardiovascular disease |
5 |
|
chinese medicine |
5 |
|
cognitive dysfunction |
5 |
|
cognitive dysfunctions |
5 |
|
cytochrome p-450 cyp2e1 - antagonists & inhibitors - metabolism |
5 |
|
cytokines - genetics - metabolism |
5 |
|
cytoprotection |
5 |
|
drug-induced liver injury - etiology - genetics - metabolism - pathology - prevention & control |
5 |
|
drugs, chinese herbal - isolation & purification - pharmacology |
5 |
|
drugs, chinese herbal - pharmacology - therapeutic use |
5 |
|
endocrinology |
5 |
|
endothelin-1 |
5 |
|
enzyme inhibitors - pharmacology |
5 |
|
fibrosis |
5 |
|
gene expression regulation, enzymologic - drug effects |
5 |
|
inflammation mediators - metabolism |
5 |
|
lipid peroxidation - drug effects |
5 |
|
liver |
5 |
|
liver - drug effects - metabolism - pathology |
5 |
|
membrane shape stability |
5 |
|
mice, inbred c57bl |
5 |
|
necrosis |
5 |
|
neurodegeneration |
5 |
|
neuron injury |
5 |
|
nf-kappa b - metabolism |
5 |
|
nitric oxide - metabolism |
5 |
|
non-alcoholic fatty liver disease |
5 |
|
nuclear factor kappa-b |
5 |
|
periodontitis |
5 |
|
plants, medicinal |
5 |
|
retinal ganglion cell |
5 |
|
sevoflurane |
5 |
|
synapse |
5 |
|
tau phosphorylation |
5 |
|
transfection |
5 |
|
426 apoptosis/cell death |
4 |
|
530 ganglion cells |
4 |
|
6-hydroxydopamine |
4 |
|
685 retina |
4 |
|
alzheimer disease - metabolism - prevention & control |
4 |
|
animal model |
4 |
|
apoptosis - drug effects |
4 |
|
arabinogalactan-protein |
4 |
|
astrocyte |
4 |
|
atomic force microscopy |
4 |
|
axon retraction |
4 |
|
baicalin |
4 |
|
blood-brain barrier |
4 |
|
blood-brain barrier - drug effects |
4 |
|
blood-retinal barrier |
4 |
|
blood-retinal barrier - drug effects - physiopathology |
4 |
|
blotting, western |
4 |
|
brain |
4 |
|
brain edema - etiology - pathology - physiopathology - prevention and control |
4 |
|
brain slice |
4 |
|
caspase 3 |
4 |
|
caspase 3 - metabolism |
4 |
|
caspases - metabolism |
4 |
|
cell adhesion |
4 |
|
cell line, transformed |
4 |
|
cell line, tumor |
4 |
|
cell survival - drug effects |
4 |
|
cell transplantation |
4 |
|
chinese herbal medicine |
4 |
|
cinnamon bark |
4 |
|
cognition |
4 |
|
corticosterone |
4 |
|
depression |
4 |
|
dose-response relationship, drug |
4 |
|
embryo, mammalian |
4 |
|
epithelial cells - virology |
4 |
|
epstein-barr virus infections - complications |
4 |
|
glial cell |
4 |
|
herpesvirus 4, human - isolation & purification |
4 |
|
insulin signaling |
4 |
|
l-lactate dehydrogenase - metabolism |
4 |
|
medicine, east asian traditional |
4 |
|
mgo |
4 |
|
mice, nude |
4 |
|
molecular weight |
4 |
|
n ε- (carboxymethyl)lysine (cml) |
4 |
|
nasopharynx - virology |
4 |
|
neuron adhesion |
4 |
|
neuron mechanics |
4 |
|
neurons - cytology - drug effects - physiology |
4 |
|
neurons - drug effects |
4 |
|
neurons - drug effects - metabolism |
4 |
|
neurons - drug effects - pathology |
4 |
|
neuroscience |
4 |
|
oxidopamine - toxicity |
4 |
|
pentosidine |
4 |
|
peroxynitrite |
4 |
|
plant extracts - pharmacology |
4 |
|
postoperative cognitive dysfunction |
4 |
|
proanthocyanidin |
4 |
|
rat |
4 |
|
reactive oxygen species - metabolism |
4 |
|
reperfusion injury - drug therapy |
4 |
|
rna, viral - analysis |
4 |
|
stroke |
4 |
|
stroke - complications - drug therapy - pathology - physiopathology |
4 |
|
synaptophysin |
4 |
|
traumatic injury |
4 |
|
viscoelasticity |
4 |
|
1-methyl-4-phenylpyridinium - toxicity |
3 |
|
8-ohg |
3 |
|
adhesion |
3 |
|
administration, oral |
3 |
|
age-related macular degeneration |
3 |
|
alkaline extraction |
3 |
|
alzheimer |
3 |
|
alzheimer's disease. |
3 |
|
amyloid |
3 |
|
amyloid beta-peptides - chemistry - genetics - metabolism |
3 |
|
amyloid beta-peptides - drug effects - metabolism |
3 |
|
amyloid beta-peptides - metabolism |
3 |
|
amyloid beta-peptides - toxicity |
3 |
|
analysis of variance |
3 |
|
anesthetics |
3 |
|
animal tissue |
3 |
|
antimanic agents - pharmacology |
3 |
|
antioxidant (2.084) |
3 |
|
autophagy |
3 |
|
beta amyloid |
3 |
|
biological markers - analysis |
3 |
|
blotting, western - methods |
3 |
|
brain - drug effects - metabolism |
3 |
|
brain diseases - immunology - physiopathology - therapy |
3 |
|
ca2 |
3 |
|
calcium |
3 |
|
calpain-2 |
3 |
|
calpain-5 |
3 |
|
caspase-3 |
3 |
|
caspases |
3 |
|
catechin - administration and dosage - analogs and derivatives - chemistry - pharmacology |
3 |
|
cell count |
3 |
|
cell death - drug effects |
3 |
|
cell differentiation - drug effects |
3 |
|
cell shape |
3 |
|
cell size |
3 |
|
cells |
3 |
|
central nervous system - cytology - immunology - metabolism |
3 |
|
central nervous system agents - administration and dosage - toxicity |
3 |
|
cerebral cortex - cytology |
3 |
|
chemokine ccl2 - immunology |
3 |
|
chronic disease |
3 |
|
cigarette smoking |
3 |
|
clinical trial (2.172) |
3 |
|
cognitive impairment |
3 |
|
crystallin |
3 |
|
crystallins - metabolism |
3 |
|
death associated protein kinase |
3 |
|
dentate gyrus |
3 |
|
dexmedetomidine |
3 |
|
differentiation |
3 |
|
dissection |
3 |
|
dna fragmentation - drug effects |
3 |
|
drug interactions |
3 |
|
dynamics |
3 |
|
elasticity |
3 |
|
electrophoresis, gel, two-dimensional |
3 |
|
endoplasmic reticulum |
3 |
|
endoplasmic reticulum - metabolism - ultrastructure |
3 |
|
experimental glaucoma |
3 |
|
eye |
3 |
|
ganoderma lucidum |
3 |
|
glaucoma - immunology - pathology |
3 |
|
glaucoma - physiopathology |
3 |
|
glaucoma. |
3 |
|
green tea polyphenols/egcg |
3 |
|
hippocampus |
3 |
|
hippocampus - cytology |
3 |
|
hypothermia |
3 |
|
ibuprofen |
3 |
|
igf-1 |
3 |
|
immune system processes - immunology |
3 |
|
immunohistochemistry |
3 |
|
immunotherapy |
3 |
|
indentation |
3 |
|
indoles - diagnostic use |
3 |
|
inflammation - immunology - physiopathology - prevention & control |
3 |
|
injection |
3 |
|
inner nuclear layer |
3 |
|
insulin-like growth factor i/immunology |
3 |
|
intraocular pressure |
3 |
|
issue 10 |
3 |
|
issue 16 |
3 |
|
issue 60 |
3 |
|
l. barbarum |
3 |
|
laser coagulation |
3 |
|
lasers |
3 |
|
lithium chloride - pharmacology |
3 |
|
loads (forces) |
3 |
|
lycium barbarum l |
3 |
|
lycium extract |
3 |
|
lysosomes - metabolism - ultrastructure |
3 |
|
macrophage |
3 |
|
mcp-1/ccl2 |
3 |
|
memory |
3 |
|
mice, transgenic |
3 |
|
microglia - immunology - pathology |
3 |
|
microtubules - metabolism |
3 |
|
models, neurological |
3 |
|
morphometric analysis |
3 |
|
mpp+ |
3 |
|
nerium - chemistry |
3 |
|
nerve degeneration - drug therapy - etiology - physiopathology |
3 |
|
neural cell adhesion molecule |
3 |
|
neurites - drug effects - metabolism - pathology |
3 |
|
neuroblastoma |
3 |
|
neuroglia - immunology - metabolism |
3 |
|
neuroimmunomodulation |
3 |
|
neuronal apoptosis |
3 |
|
neurons - cytology - drug effects - metabolism |
3 |
|
neurons - cytology - metabolism |
3 |
|
neurons - drug effects - metabolism - pathology |
3 |
|
neuroprotective agents - administration and dosage - chemistry - pharmacology |
3 |
|
neuroprotective agents - pharmacology - therapeutic use |
3 |
|
neuroprotective drug |
3 |
|
neurotoxicity |
3 |
|
neurotoxins - toxicity |
3 |
|
neurotrophins |
3 |
|
nocodazole - metabolism |
3 |
|
ocular hypertension |
3 |
|
ocular hypertension - etiology |
3 |
|
ocular hypertension - pathology - physiopathology |
3 |
|
ocular hypertension - physiopathology |
3 |
|
ophthalmology research |
3 |
|
optic nerve (on) |
3 |
|
oxidopamine - administration and dosage - toxicity |
3 |
|
parkinson's disease |
3 |
|
partial transection |
3 |
|
peptide fragments - pharmacology |
3 |
|
peptide fragments - toxicity |
3 |
|
plant extracts - chemistry |
3 |
|
polysaccharide |
3 |
|
potassium ions |
3 |
|
prodrug/pegcg |
3 |
|
propofol |
3 |
|
protein kinase r |
3 |
|
protein kinases |
3 |
|
recombinant fusion proteins - genetics - metabolism |
3 |
|
reishi - chemistry |
3 |
|
relaxation time |
3 |
|
retina -- diseases. |
3 |
|
retinal degeneration |
3 |
|
retinal degeneration - drug therapy - etiology - physiopathology |
3 |
|
retinal ganglion cells |
3 |
|
retinal ganglion cells - drug effects - metabolism |
3 |
|
retinal ganglion cells - drug effects - pathology |
3 |
|
retinal vein occlusion - etiology - physiopathology |
3 |
|
retinitis pigmentosa |
3 |
|
retinoic acid |
3 |
|
retrograde labeling |
3 |
|
secondary degeneration |
3 |
|
signal transduction |
3 |
|
signal transduction - drug effects |
3 |
|
signal transduction - immunology |
3 |
|
stereo investigator |
3 |
|
superior colliculus |
3 |
|
synapses - drug effects - metabolism |
3 |
|
synaptophysin - drug effects - metabolism |
3 |
|
synaptotoxicity |
3 |
|
systemic inflammation |
3 |
|
tau proteins |
3 |
|
thickness |
3 |
|
time factors |
3 |
|
tissue clearing |
3 |
|
traditional chinese medicine (2.592) |
3 |
|
treatment outcome |
3 |
|
tretinoin - pharmacology |
3 |
|
tubulin - metabolism |
3 |
|
tubulin modulators - metabolism |
3 |
|
unfolded protein responses |
3 |
|
up-regulation |
3 |
|
vacuoles - metabolism |
3 |
|
wolfberry |
3 |
|
β-amyloid |
3 |
|
β-amyloid peptide |
3 |
|
1h-pyrrole-2- carboxylic acid derivative |
2 |
|
2apb |
2 |
|
6-hydroxydopamine(6-ohda) |
2 |
|
absence of side effects |
2 |
|
absolute quantification |
2 |
|
acetylcholine - metabolism |
2 |
|
actin |
2 |
|
acupuncture |
2 |
|
adeno-associated virus |
2 |
|
adiponectin |
2 |
|
adrenergic agents - toxicity |
2 |
|
adult |
2 |
|
aging - drug effects |
2 |
|
aging - drug effects - metabolism |
2 |
|
alzheimer disease - complications - pathology - therapy |
2 |
|
alzheimer disease - metabolism - pathology - prevention and control |
2 |
|
alzheimer's disease -- congresses |
2 |
|
alzheimer-like pathology |
2 |
|
amyloid beta-peptides - antagonists & inhibitors - toxicity |
2 |
|
amyloid beta-peptides - chemistry - metabolism |
2 |
|
amyloid beta-peptides - chemistry - pharmacology |
2 |
|
amyloid peptide |
2 |
|
amyloid precursor protein |
2 |
|
amyloid-β |
2 |
|
ananas - chemistry |
2 |
|
ananas comosus |
2 |
|
anterior cingulate cortex |
2 |
|
antidepressant |
2 |
|
antigenicity |
2 |
|
antioxidants - pharmacology |
2 |
|
aphrodisiac |
2 |
|
asthma |
2 |
|
automation |
2 |
|
basic-leucine zipper transcription factors - metabolism |
2 |
|
bbb permeability |
2 |
|
behavior |
2 |
|
behavior, animal |
2 |
|
blood vessel |
2 |
|
blood–brain barrier |
2 |
|
boron compounds - pharmacology |
2 |
|
brain - drug effects - metabolism - physiopathology |
2 |
|
brain - embryology - metabolism |
2 |
|
brain - physiology |
2 |
|
brain-derived nerve growth factor |
2 |
|
c-jun n-terminal kinase |
2 |
|
calcium - metabolism |
2 |
|
calcium-calmodulin-dependent protein kinase type 2 |
2 |
|
calcium-calmodulin-dependent protein kinases - antagonists & inhibitors - metabolism |
2 |
|
calcium/calmodulin kinase-ii |
2 |
|
carboxylic acids - chemistry - isolation and purification - pharmacology |
2 |
|
carrier proteins - metabolism |
2 |
|
caspase 3 - drug effects |
2 |
|
caspase 8 |
2 |
|
caspase 9 |
2 |
|
caspase-9 |
2 |
|
caspases - antagonists & inhibitors - metabolism |
2 |
|
cell culture techniques |
2 |
|
cell proliferation |
2 |
|
cellular events |
2 |
|
cellular senescence |
2 |
|
cerebral cortex - cytology - embryology |
2 |
|
cerebral cortex - cytology - metabolism |
2 |
|
cerebral cortex - cytology - physiology |
2 |
|
cerebral cortex - drug effects - metabolism - pathology |
2 |
|
cerebral cortex - pathology |
2 |
|
cho cells |
2 |
|
chromatography, high pressure liquid |
2 |
|
clarity |
2 |
|
clinical practices |
2 |
|
clinical trial (topic) |
2 |
|
coculture techniques |
2 |
|
cognitive functions |
2 |
|
cognitive training |
2 |
|
complement factors |
2 |
|
cortisol |
2 |
|
cricetinae |
2 |
|
cytokines |
2 |
|
cytokines - physiology |
2 |
|
cytoprotective effects |
2 |
|
darkness - adverse effects |
2 |
|
delipidation |
2 |
|
delirium |
2 |
|
delirium - physiopathology |
2 |
|
dementia -- congresses |
2 |
|
depression - etiology - pathology |
2 |
|
despression |
2 |
|
diagnosis |
2 |
|
dietary supplement |
2 |
|
dietary supplements |
2 |
|
disease progression |
2 |
|
diurnal |
2 |
|
dna-binding proteins |
2 |
|
double-stranded rna-dependent protein kinase |
2 |
|
drugs, chinese herbal - administration and dosage - pharmacology |
2 |
|
eif-2 kinase - metabolism |
2 |
|
electromagnetic |
2 |
|
endoplasmic reticulum - drug effects - metabolism |
2 |
|
endoplasmic reticulum - metabolism |
2 |
|
endothelial cell |
2 |
|
enzyme activation |
2 |
|
enzyme activation - drug effects - physiology |
2 |
|
er stress |
2 |
|
eukaryotic initiation factor 2α |
2 |
|
eukaryotic initiation factor-2 |
2 |
|
eukaryotic initiation factor-2 - metabolism |
2 |
|
excitotoxicity |
2 |
|
exercise |
2 |
|
focal adhesions |
2 |
|
free radical scavengers - metabolism |
2 |
|
free radicals |
2 |
|
gastroenterology medical sciences |
2 |
|
general anaesthesia |
2 |
|
ginseng |
2 |
|
glucose metabolism |
2 |
|
glut1 |
2 |
|
glutamate |
2 |
|
glutamic acid - metabolism |
2 |
|
glutamic acid - toxicity |
2 |
|
grp78 |
2 |
|
heat-shock proteins |
2 |
|
herbal medicine |
2 |
|
homocysteine |
2 |
|
homocysteine - antagonists and inhibitors - toxicity |
2 |
|
hsp90 heat-shock proteins - metabolism |
2 |
|
human post mortem brain |
2 |
|
illness behavior - physiology |
2 |
|
immune response |
2 |
|
immunosuppressive agents - pharmacology |
2 |
|
indoles - metabolism |
2 |
|
inflammation - physiopathology |
2 |
|
intracellular space - drug effects - metabolism |
2 |
|
l-lactate dehydrogenase - drug effects |
2 |
|
lewy body dementias |
2 |
|
lewy body pathology |
2 |
|
light deprivation |
2 |
|
locus coeruleus |
2 |
|
lycium barbarum (wolfberry) |
2 |
|
lycium barbsarum |
2 |
|
macrocyclic compounds |
2 |
|
magnetic resonance spectroscopy |
2 |
|
mating |
2 |
|
mechanotransduction |
2 |
|
methylated resveratrol |
2 |
|
methylation |
2 |
|
microfluidics |
2 |
|
microrna |
2 |
|
microtubule |
2 |
|
mitochondria - drug effects - metabolism - physiology |
2 |
|
mitogen-activated protein kinases - metabolism |
2 |
|
models, biological |
2 |
|
models, chemical |
2 |
|
molecular chaperones - metabolism |
2 |
|
mongolian gerbil |
2 |
|
motor activity |
2 |
|
muscle |
2 |
|
naloxone - pharmacology |
2 |
|
neoplasm proteins - metabolism |
2 |
|
nerium indicum |
2 |
|
nerve degeneration - complications - therapy |
2 |
|
nerve regeneration |
2 |
|
neural regeneration |
2 |
|
neurodegenerative diseases - drug therapy - metabolism - physiopathology |
2 |
|
neurodegenerative diseases - drug therapy - prevention & control |
2 |
|
neurodegenerative diseases - metabolism - pathology - physiopathology |
2 |
|
neurogenesis |
2 |
|
neuroglia - cytology - drug effects - physiology |
2 |
|
neurohormones |
2 |
|
neuroimmune activation |
2 |
|
neurological disorders |
2 |
|
neuronal hypertrophy |
2 |
|
neurons - cytology - drug effects |
2 |
|
neurons - drug effects - enzymology |
2 |
|
neurons - drug effects - enzymology - pathology |
2 |
|
neurons - metabolism - pathology |
2 |
|
neurons - physiology |
2 |
|
neuroprotective agents |
2 |
|
neuroprotective agents - administration and dosage - pharmacology |
2 |
|
neuroprotective agents - antagonists & inhibitors - metabolism |
2 |
|
neurotoxins - metabolism |
2 |
|
neurovascular dysregulation |
2 |
|
nitrites - metabolism |
2 |
|
nutraceuticals |
2 |
|
obesity |
2 |
|
okadaic acid |
2 |
|
opacity |
2 |
|
optic nerve |
2 |
|
oxazoles - pharmacology |
2 |
|
oxidativestress |
2 |
|
oxidopamine - pharmacology |
2 |
|
oxyresveratrol |
2 |
|
parkinson disease |
2 |
|
parkinson disease - prevention & control - therapy |
2 |
|
parkinson's disease dementia |
2 |
|
parkinson'sdisease |
2 |
|
pentanoic acids - chemistry - isolation and purification - pharmacology |
2 |
|
peptides - chemistry |
2 |
|
pericytes |
2 |
|
perioperative neurocognitive disorders |
2 |
|
perk |
2 |
|
pinostilbene |
2 |
|
plant structures - chemistry |
2 |
|
poales |
2 |
|
point-of-care |
2 |
|
polysaccharides |
2 |
|
polysaccharides - pharmacology |
2 |
|
post-translational modification |
2 |
|
posterior cingulate cortex |
2 |
|
postoperative neurocognitive disorders |
2 |
|
precipitin tests |
2 |
|
prostaglandins |
2 |
|
protein biosynthesis - physiology |
2 |
|
protein denaturation - physiology |
2 |
|
protein loss |
2 |
|
protein translation control |
2 |
|
protein transport - physiology |
2 |
|
psychiatry and neurology biology |
2 |
|
pyrroles - chemistry - isolation and purification - pharmacology |
2 |
|
reducing stress |
2 |
|
renal impairment |
2 |
|
reproduction |
2 |
|
resistance exercise |
2 |
|
resveratrol |
2 |
|
retinal disease |
2 |
|
risk factors |
2 |
|
rna, messenger - metabolism |
2 |
|
schisantherin a |
2 |
|
seasonal affective disorder (sad) |
2 |
|
seasonal affective disorder - metabolism - pathology |
2 |
|
senescent cells |
2 |
|
senolytic medicine |
2 |
|
senolytics |
2 |
|
sevoflurane-induced neurotoxicity |
2 |
|
sexual behaviors |
2 |
|
sickness |
2 |
|
sickness behavior |
2 |
|
sickness response |
2 |
|
signal transduction - physiology |
2 |
|
smoking |
2 |
|
spinal cord injury |
2 |
|
stiffness matrix |
2 |
|
stilbenes - chemistry - pharmacology |
2 |
|
stilbenes - pharmacology |
2 |
|
subventricular zone |
2 |
|
sulfur compounds - chemistry - isolation and purification - pharmacology |
2 |
|
sulfur-containing constituents |
2 |
|
surgery |
2 |
|
synaptic proteins |
2 |
|
synaptotagmin |
2 |
|
tacrolimus - pharmacology |
2 |
|
thapsigargin |
2 |
|
three-dimensional imaging |
2 |
|
three-dimensional visualization |
2 |
|
traditional chinese medicine |
2 |
|
transcription factors |
2 |
|
tubulin |
2 |
|
tyrosinase inhibitors |
2 |
|
ubiquitin proteasome system |
2 |
|
verbena officinalis |
2 |
|
α-synuclein |
2 |
|
1-phenyl 2-thiourea |
1 |
|
4,4'-diisothiocyanostilbene-2,2'-disulfonic acid - pharmacology |
1 |
|
6-ohda |
1 |
|
a-synuclein |
1 |
|
abeta |
1 |
|
acid-base equilibrium - physiology |
1 |
|
acidosis |
1 |
|
acidosis - physiopathology |
1 |
|
acidosis, lactic - pathology |
1 |
|
acidosis, lactic - physiopathology |
1 |
|
acute respiratory distress syndrome (ards) |
1 |
|
adjuvants, immunologic |
1 |
|
adp ribosylation factor 6 |
1 |
|
aged |
1 |
|
aged, 80 and over |
1 |
|
aging - metabolism |
1 |
|
akt |
1 |
|
alzeimer’s disease |
1 |
|
alzheimer disease - complications - therapy |
1 |
|
alzheimer disease - genetics |
1 |
|
alzheimer disease - metabolism - pathology |
1 |
|
alzheimer disease - metabolism - physiopathology - therapy |
1 |
|
alzheimer disease - physiopathology - prevention and control |
1 |
|
alzheimer’s neurodegenerative diseases |
1 |
|
amyloid beta-protein precursor |
1 |
|
amyloid beta-protein precursor - chemistry - metabolism |
1 |
|
amyloid-β a4 precursor protein-binding family b member 1 |
1 |
|
angiotensin-converting enzyme 2 (ace-2) |
1 |
|
animal models |
1 |
|
animals, newborn |
1 |
|
anions |
1 |
|
anti-ganglioside complex |
1 |
|
anti-inflammatory agents, non-steroidal - pharmacology |
1 |
|
anti-inflammatory agents, non-steroidal - therapeutic use |
1 |
|
antibodies |
1 |
|
antigens, cd |
1 |
|
antigens, cd147 |
1 |
|
antigens, neoplasm |
1 |
|
antigens, surface |
1 |
|
antiporters - physiology |
1 |
|
anxiety |
1 |
|
apoptosis - physiology |
1 |
|
arachidonic acid |
1 |
|
arachidonic acid - physiology |
1 |
|
astrocytes |
1 |
|
astrocytes - cytology - drug effects - metabolism |
1 |
|
atherosclerosis |
1 |
|
attentional bias |
1 |
|
autism spectrum disorders |
1 |
|
autocamtide-related inhibitory peptide |
1 |
|
autophagy-related 14 |
1 |
|
avian proteins |
1 |
|
basal forebrain |
1 |
|
bcl-2 family |
1 |
|
bcl-associated death protein |
1 |
|
beta-amyloid peptide |
1 |
|
bicarbonates - administration & dosage |
1 |
|
binding, competitive |
1 |
|
biomarker |
1 |
|
bis-carboxyethyl carboxyfluorescein (bcecf) |
1 |
|
blood |
1 |
|
blood proteins |
1 |
|
brain - cytology - enzymology |
1 |
|
brain - cytology - physiology |
1 |
|
brain - metabolism |
1 |
|
brain border niches |
1 |
|
brain chemistry - genetics |
1 |
|
brain damage, chronic - physiopathology |
1 |
|
brain edema |
1 |
|
brain edema - drug therapy - pathology |
1 |
|
brain edema - etiology - metabolism |
1 |
|
brain edema - physiopathology |
1 |
|
brain injuries - pathology - physiopathology |
1 |
|
brain injuries - physiopathology |
1 |
|
brain injury |
1 |
|
brain ischemia - physiopathology |
1 |
|
brain neoplasms |
1 |
|
brefeldin a - pharmacology |
1 |
|
bumetanide - pharmacology |
1 |
|
c6 glioma |
1 |
|
c6 glioma cell |
1 |
|
c6 glioma cells |
1 |
|
calcimycin - toxicity |
1 |
|
calcium - physiology |
1 |
|
calcium channels - physiology |
1 |
|
calcium homeostasis |
1 |
|
calcium ions |
1 |
|
calcium signaling - drug effects - physiology |
1 |
|
calcium signaling - physiology |
1 |
|
camkii |
1 |
|
carbazoles - pharmacology |
1 |
|
carbon dioxide - administration & dosage |
1 |
|
carrier proteins - antagonists & inhibitors - physiology |
1 |
|
caspase |
1 |
|
cell communication - drug effects |
1 |
|
cell culture |
1 |
|
cell death |
1 |
|
cell death - physiology |
1 |
|
cell fractionation |
1 |
|
cell line |
1 |
|
cell nucleus - metabolism |
1 |
|
cell nucleus - ultrastructure |
1 |
|
cell proliferation - drug effects |
1 |
|
cell size - drug effects |
1 |
|
cell size - physiology |
1 |
|
cell survival - physiology |
1 |
|
cell swelling |
1 |
|
cerebral cortex |
1 |
|
cerebral inflammation |
1 |
|
cerebral ventricles - physiopathology |
1 |
|
cerebral ventricles - secretion |
1 |
|
cerebrospinal fluid - physiology |
1 |
|
cerebrospinal fluid - secretion |
1 |
|
charybdotoxin - pharmacology |
1 |
|
chloride-bicarbonate antiporters |
1 |
|
chlorides - administration & dosage |
1 |
|
cholinergic system |
1 |
|
chrysin |
1 |
|
circadian rhythm |
1 |
|
cl-/hco3- exchanger |
1 |
|
closed cranial window |
1 |
|
coenzyme q10 |
1 |
|
copper |
1 |
|
coronavirus disease 2019 (covid-19) |
1 |
|
cortical cultures |
1 |
|
cricetulus |
1 |
|
culture media |
1 |
|
cyclic n-oxides - metabolism |
1 |
|
cytotoxic brain |
1 |
|
cytotoxic brain edema |
1 |
|
ddt - toxicity |
1 |
|
dementia |
1 |
|
diabetes mellitus · |
1 |
|
diagonal band of broca |
1 |
|
dithiothreitol |
1 |
|
dna primers |
1 |
|
dopamine - metabolism |
1 |
|
dopamine uptake |
1 |
|
down-regulation |
1 |
|
drp-1 |
1 |
|
drug synergism |
1 |
|
drugs, chinese herbal - chemistry - pharmacology |
1 |
|
dural lymphatics |
1 |
|
eif2α |
1 |
|
electron paramagnetic resonance |
1 |
|
electron spin resonance spectroscopy |
1 |
|
elf2cα |
1 |
|
endotoxin |
1 |
|
engulfment and cell motility protein 1 |
1 |
|
environment enrichment |
1 |
|
enzyme activation - drug effects |
1 |
|
enzyme inhibitors - therapeutic use |
1 |
|
epilepsy, temporal lobe - physiopathology |
1 |
|
er stress oxyresveratrol |
1 |
|
escherichia coli |
1 |
|
eukaryotic initiation factor-2 - antagonists and inhibitors - metabolism |
1 |
|
eukaryotic initiation factor-2α |
1 |
|
excitatory amino acid agonists - pharmacology |
1 |
|
extracellular space - metabolism |
1 |
|
extracellular space - physiology |
1 |
|
fc receptor |
1 |
|
fe65 |
1 |
|
fission and fusion |
1 |
|
flavonoids |
1 |
|
flow cytometry |
1 |
|
flow-cytometry |
1 |
|
flowers - chemistry |
1 |
|
fluorescent antibody technique |
1 |
|
fluorescent dyes |
1 |
|
fluorescent dyes - pharmacokinetics |
1 |
|
formazans - pharmacology |
1 |
|
gc-ms |
1 |
|
gene delivery |
1 |
|
gene expression - drug effects |
1 |
|
gene expression regulation |
1 |
|
gene expression regulation - drug effects |
1 |
|
gene therapy |
1 |
|
genistein - toxicity |
1 |
|
glia |
1 |
|
glial cell swelling |
1 |
|
glial cells |
1 |
|
glial swelling |
1 |
|
glioma |
1 |
|
glioma - metabolism - pathology |
1 |
|
glutamate toxicity |
1 |
|
glutamic acid - pharmacology |
1 |
|
glycoconjugates |
1 |
|
glycogen synthase kinase 3 - metabolism |
1 |
|
glycoproteins |
1 |
|
glymphatic |
1 |
|
gmf-β |
1 |
|
go6976 |
1 |
|
granulovacuolar degeneration |
1 |
|
guillain-barré syndrome |
1 |
|
gulp1 |
1 |
|
gw274150 |
1 |
|
homeostasis - physiology |
1 |
|
huntington’s disease |
1 |
|
hydrogen-ion concentration |
1 |
|
hydroxyl radical - metabolism |
1 |
|
hyperhomocysteinemia |
1 |
|
hypothermia, induced |
1 |
|
immune system - drug effects |
1 |
|
indoles - pharmacology |
1 |
|
inflammation - chemically induced - metabolism |
1 |
|
infusion edema model |
1 |
|
infusion oedema model |
1 |
|
inos |
1 |
|
inositol 1,4,5-trisphosphate - metabolism |
1 |
|
inositol phosphates - pharmacology |
1 |
|
inositol phosphates - therapeutic use |
1 |
|
interferon-gamma - pharmacology |
1 |
|
interferon-inducing protein kinase |
1 |
|
interferons - pharmacology |
1 |
|
intracellular fluid - physiology |
1 |
|
intracranial pressure |
1 |
|
ionophores - toxicity |
1 |
|
ip3 receptor |
1 |
|
iron - antagonists & inhibitors - metabolism |
1 |
|
irritable bowel syndrome |
1 |
|
issue 145 |
1 |
|
kainic acid |
1 |
|
kainic acid - pharmacology |
1 |
|
kinetics |
1 |
|
kn62 |
1 |
|
kn93 |
1 |
|
l-lactate dehydrogenase - analysis |
1 |
|
l-lactate dehydrogenase - secretion |
1 |
|
lactacidosis |
1 |
|
lactic acid |
1 |
|
lactic acid - metabolism |
1 |
|
lactic acidosis |
1 |
|
laparotomy |
1 |
|
lewy body dementia |
1 |
|
lipopolysaccharide |
1 |
|
lipopolysaccharides - antagonists & inhibitors - toxicity |
1 |
|
lipopolysaccharides - pharmacology |
1 |
|
lipopolysaccharides - toxicity |
1 |
|
macroautophagy |
1 |
|
macrocephaly |
1 |
|
macrophages |
1 |
|
macrophages - drug effects - immunology |
1 |
|
macrophages - drug effects - immunology - metabolism |
1 |
|
map kinase kinase 4 - metabolism |
1 |
|
melanogenesis |
1 |
|
melatonin |
1 |
|
membrane glycoproteins - metabolism |
1 |
|
memory impairment |
1 |
|
mesencephalon - cytology |
1 |
|
mesencephalon - cytology - drug effects - embryology - metabolism |
1 |
|
metabolic diseases - etiology |
1 |
|
microglia - cytology - drug effects - metabolism |
1 |
|
microglia - drug effects - immunology - metabolism |
1 |
|
microglia - metabolism |
1 |
|
midbrain |
1 |
|
mild cognitive impairment |
1 |
|
minireview |
1 |
|
mir-132 |
1 |
|
mitochondria |
1 |
|
mitochondria - drug effects - physiology - ultrastructure |
1 |
|
mitochondria - metabolism |
1 |
|
mitochondrial diseases - metabolism |
1 |
|
mitochondrial membrane potential |
1 |
|
mitochondrial membranes - drug effects - physiology |
1 |
|
mitogen-activated protein kinases - antagonists & inhibitors - metabolism |
1 |
|
monoclonal antibody |
1 |
|
monocytes - drug effects - immunology |
1 |
|
mossy fiber sprouting |
1 |
|
mossy fibers, hippocampal - chemistry - drug effects - physiology |
1 |
|
mouse |
1 |
|
na+-k+-cl- cotransporter |
1 |
|
naloxone |
1 |
|
naloxone stereoisomer |
1 |
|
narcotic antagonists - pharmacology |
1 |
|
nerve degeneration - chemically induced - physiopathology |
1 |
|
nerve degeneration - metabolism - pathology |
1 |
|
nerve degeneration - prevention & control |
1 |
|
nerve tissue proteins - analysis - genetics |
1 |
|
nerve tissue proteins - metabolism |
1 |
|
neural cell adhesion molecules |
1 |
|
neural cell adhesion molecules - chemistry - pharmacology |
1 |
|
neural cell adhesion molecules - metabolism - pharmacology |
1 |
|
neurite outgrowth |
1 |
|
neuroblastoma - metabolism - pathology |
1 |
|
neurodegenerative disease |
1 |
|
neurodegenerative diseases |
1 |
|
neurodegenerative diseases - drug therapy - enzymology |
1 |
|
neurodegenerative diseases - genetics |
1 |
|
neurodegenerative diseases - physiopathology - prevention and control |
1 |
|
neurodevelopmental disorders |
1 |
|
neuroglia - cytology - drug effects - enzymology |
1 |
|
neuroglia - cytology - drug effects - metabolism |
1 |
|
neuroglia - cytology - enzymology |
1 |
|
neuroglia - drug effects - immunology - physiology |
1 |
|
neuroglia - drug effects - pathology |
1 |
|
neuroglia - pathology |
1 |
|
neuroglia - physiology |
1 |
|
neuroimmune responses |
1 |
|
neurology |
1 |
|
neuron-glia interaction |
1 |
|
neuronal death |
1 |
|
neuronal inhibition |
1 |
|
neuronalapoptosis |
1 |
|
neurons |
1 |
|
neuropathology |
1 |
|
neuroprotection effects |
1 |
|
neuroprotective agents - chemistry - isolation & purification - pharmacology |
1 |
|
neurotoxicology |
1 |
|
nitric oxide |
1 |
|
nitric oxide - biosynthesis |
1 |
|
nitric oxide synthase - genetics |
1 |
|
nitric oxide synthase - genetics - metabolism |
1 |
|
nitric oxide synthase - metabolism |
1 |
|
nitric oxide synthase type ii |
1 |
|
nitric oxide synthase type ii - metabolism |
1 |
|
nitrogen oxides - antagonists & inhibitors - metabolism |
1 |
|
non-heme iron-nitrosyl complex |
1 |
|
nordihydroguaiaretic acid - pharmacology |
1 |
|
nuclear proteins - analysis - genetics |
1 |
|
nuclear proteins - metabolism |
1 |
|
nucleus basalis of meynert |
1 |
|
nurr1 |
1 |
|
orexin |
1 |
|
p38 map kinase |
1 |
|
p38 mitogen-activated protein kinases |
1 |
|
parkinson’s disease |
1 |
|
pc12 cells |
1 |
|
peripheral blood |
1 |
|
peripheral inflammation |
1 |
|
peripheral nervous system |
1 |
|
phosphorylation - drug effects |
1 |
|
phytotherapy |
1 |
|
pkc |
1 |
|
pkr |
1 |
|
plant extracts - chemistry - isolation & purification - pharmacology |
1 |
|
plant extracts - immunology - pharmacology |
1 |
|
plasma |
1 |
|
plasma membrane targeting |
1 |
|
polysaccharides - chemistry - isolation & purification - pharmacology |
1 |
|
post-transcription |
1 |
|
potassium |
1 |
|
potassium chloride - pharmacology |
1 |
|
prenatal exposure to maternal cigarette smoking |
1 |
|
presenilins |
1 |
|
presenilins - metabolism |
1 |
|
promoter |
1 |
|
promoter regions, genetic |
1 |
|
proteasome |
1 |
|
protein binding - physiology |
1 |
|
protein kinase |
1 |
|
protein kinase c |
1 |
|
protein kinase c - drug effects - physiology |
1 |
|
protein kinase c - metabolism |
1 |
|
protein kinase inhibitors |
1 |
|
protein kinases - metabolism |
1 |
|
protein synthesis |
1 |
|
protein synthesis inhibitors - pharmacology |
1 |
|
protein translation |
1 |
|
proteomic analysis |
1 |
|
proto-oncogene proteins c-bcl-2 - metabolism |
1 |
|
prunella |
1 |
|
prunella - chemistry |
1 |
|
psychiatric disease |
1 |
|
psychiatry and neurology |
1 |
|
pten |
1 |
|
pten hamartoma tumor syndrome |
1 |
|
quercetin - toxicity |
1 |
|
rabbits |
1 |
|
ras proteins - metabolism |
1 |
|
rats, inbred f344 |
1 |
|
receptors, opioid - antagonists & inhibitors |
1 |
|
remission, spontaneous |
1 |
|
resolution of edema fluid |
1 |
|
resolution of oedema fluid |
1 |
|
reverse transcriptase polymerase chain reaction |
1 |
|
review |
1 |
|
rna processing, post-transcriptional - drug effects |
1 |
|
rna, messenger - analysis |
1 |
|
rna, messenger - genetics |
1 |
|
rna, messenger - genetics - metabolism |
1 |
|
rna, untranslated - genetics |
1 |
|
sb202190 |
1 |
|
severe acute respiratory syndrome coronavirus 2 (sars-cov-2) |
1 |
|
sh-sy5y |
1 |
|
silica nanoparticles |
1 |
|
sleep |
1 |
|
sleep disorders |
1 |
|
sodium-potassium-chloride symporters |
1 |
|
sp1 |
1 |
|
sp1 transcription factor - genetics - immunology - metabolism |
1 |
|
sp1 transcription factor - physiology |
1 |
|
spleen - cytology - drug effects |
1 |
|
statistics, nonparametric |
1 |
|
stereoisomerism |
1 |
|
stilbenes |
1 |
|
stress granules |
1 |
|
stress kinase |
1 |
|
subarachnoid space |
1 |
|
subarachnoid space - physiopathology |
1 |
|
subarachnoid space - secretion |
1 |
|
superoxide |
1 |
|
superoxides - antagonists & inhibitors - metabolism |
1 |
|
superoxides - metabolism |
1 |
|
sympatholytics - pharmacology |
1 |
|
synapses - physiology |
1 |
|
targeted metabolomics |
1 |
|
tau proteins - metabolism |
1 |
|
taurine |
1 |
|
taurine - metabolism - pharmacokinetics |
1 |
|
temporal lobe epilepsy |
1 |
|
tetradecanoylphorbol acetate - pharmacology |
1 |
|
tetrazolium salts - pharmacology |
1 |
|
topography |
1 |
|
transcription factor |
1 |
|
transcription, genetic |
1 |
|
transcription, genetic - drug effects |
1 |
|
traumatic brain injury |
1 |
|
triple (ps1m146v/appswe/taup301l) transgenic mice |
1 |
|
trpc1 |
1 |
|
tumor cells, cultured |
1 |
|
tumor cells, cultured - drug effects - pathology |
1 |
|
tumor necrosis factor |
1 |
|
tumor necrosis factor-alpha - analysis |
1 |
|
tumor necrosis factor-alpha - biosynthesis |
1 |
|
tumor necrosis factor-alpha - metabolism |
1 |
|
tumor necrosis factor-alpha - pharmacology |
1 |
|
tumor necrosis factor-alpha - secretion |
1 |
|
tumor necrosis factor-α |
1 |
|
two-dimensional fluorescence difference gel electrophoresis |
1 |
|
tyrosinase |
1 |
|
tyrosine - pharmacokinetics |
1 |
|
uptake |
1 |
|
vasogenic brain edema |
1 |
|
vasogenic brain oedema |
1 |
|
ventral tegmental area |
1 |
|
ventriculo-cisternal perfusion |
1 |
|
verbena - chemistry |
1 |
|
voltage dependent anion channel |
1 |
|
zebrafish embryo |
1 |
|
α-internexin |
1 |
|
α-syn |
1 |
|
α-trinositol |
1 |
